H.R. 10088 — To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to conduct a study to assess the potential for expanding the safe and effective use of reprocessed single-use devices, and for other purposes.

This section requires the Secretary of Health and Human Services, acting through the Food and Drug Administration Commissioner, to conduct a study assessing expansion of safe reprocessing of single-use devices, with patient safety and infection prevention as primary criteria stratified by risk and clinical use. The study must examine FDA pathways, third-party versus in-house reprocessing, operational feasibility, financial and environmental returns, and liability issues; consider clinical outcomes, reprocessing limits, logistics, and barriers; consult hospitals, clinicians, infection prevention groups, and federal agencies; and transmit a report to Congress within one year that lists devices with reprocessing potential and recommends programs using qualified third-party reprocessors.